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month after of the surgery we applied EORTC questionnaires QLQ-C30, PR25, and 
IN-PATSAT32. The scores for each questionnaire were calculated according formulas 
and instruction in the EORTC Scoring Manual. We calculated mean and standard 
deviation for each score. Results: Global Health Status/QoL has a mean score 74.80 
(±20.74); the functional scales: physical 87.4 (±18.08); emotional 80.3 (±17.23); role 
87.6 (±24.44), social 89.4 (±20.09). Symptoms scales: fatigue 15.6 (±15.48); insomnia, 
27.3 (±30.00), pain 12 (±17.27), constipation 18.4 (±27.63), financial difficulties 17 
(±29.38) the others symptom scales showed mean scores under 10. For scales in PR25 
questionnaire, the scores were: sexual activity 72.7 (±20.68), sexual function 59.0 
(±31.45); urinary symptoms 32.5 (±21.57), symptoms related with hormonal therapy 
17.5 (±14.13), incontinence support 29.2 (±38.24). About scores for IN-PATSAT32, for 
doctors: Interpersonal skills 88.30 (±16.72); technical skills 87.23 (±19.95); capacity 
to bring information 89.01 (±17.29); availability 88.56 (±16.85); for nurse: interper-
sonal skills 87.41 (±16.74) technical skills 86.52 (±18.51); capacity to bring infor-
mation 84.40 (±19.00); availability 79.26 (±20.89); other personnel kindness 80.85 
(±20.47), access 76.86 (±23.16), waiting time 82.18 (±21.45), exchange of informa-
tion 77.66 (±22.86), comfort/cleanness 80.85 (±21.62) and general satisfaction 84.57 
(±18.46). ConClusions: The functional scales for QLQ-C30 showed a good quality 
of life, however symptom scales related to sexual function showed a diminished 
QoL, satisfaction with doctors and nurses is good, but not for other personnel.
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objeCtives: To determine the HRQoL scores in multiple myeloma patients who 
are receiving treatment in a tertiary referral hospital. Methods: Outpatients 
attended consecutively at the hematology department were enrolled, at any 
stage of treatment. We interviewed through EORTC questionnaires: QLQ30, MY20 
and INPATSAT32. The medians and percentiles were calculated. Questionnaire 
scores were calculated according to formulas and instructions of the EORTC scor-
ing manual. Results: 23 patients were analyzed; the median of age was 62.21 
years (interquartile interval 59.02-69.88). 69.56% were men. Global health status/
QoL showed a median score of 66.67 (P25= 62.5, P75= 83.33), emotional function-
ing 83.33 (P25= 58.33, P75= 91.66), pain scale 33.33 (P25= 16.66, P75= 50.00), insom-
nia 33.33 (P25= 0, P75= 33.33), fatigue 33.33 (P25= 16.66, P75= 44.44). The median for 
the body image scale was 100.00 (P25= 50.00, P75= 100.00) and future perspective 
was 77.78 (P25= 55.55, P75= 97.22), the other medians: symptoms 27.78 (P25= 13.88, 
P75= 38.88), treatment-related side effects 20.00 (P25= 8.33, P75= 36.66). In the sat-
isfaction questionnaire, the scores for the doctor showed: technical skills 75.00 
(P25= 54.16, P75= 97.91), information provided 41.67 (P25= 25.00, P75= 58.33) for nurs-
ing: technical skills 75.00 (P25= 58.33, P75= 89.58) and information provided 75.00 
(P25= 50.00, P75= 91.66), waiting times 62.50 (P25= 50.00, P75= 96.87) and in overall 
satisfaction average was 75.00 (P25= 50.00, P75= 93.75). ConClusions: Multiple 
myeloma patients treated in this hospital show favorable results on scores of qual-
ity of life in terms of symptoms of the disease and treatment-related side effects, 
especially in the fatigue. These results can be compared satisfactory accordingly 
with other reports from the international literature.
PCN189
HealtH Related Quality of life aNd PatieNt satisfaCtioN iN 
ColoReCtal CaNCeR PatieNts tReated tHRougH RadiCal suRgeRy iN 
CuRative iNteNt iN a Colo-PRoCtology CliNiCal dePaRtMeNt
Balderas-Peña L.M.A.1, Sat-Muñoz D.2, Palomares-Chacon U.R.3, Flores-Larios E.A.4,  
Ramírez-Conchas R.E.1, Salcedo-Rocha A.L.5, García de Alba-García JE5
1UMAE Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, 
Jalisco, Mexico, 2UMAE Hospital de Gineco-Obstetricia Centro Médico Nacional de Occidente IMSS, 
Guadalajara, Jalisco, Mexico, 3UMAE HE Centro Medico Nacional de Occidente Instituto Mexicano 
del Seguro Social, Guadalajara, Mexico, 4Universidad de Guadalajara, Guadalajara, Jalisco, 
Mexico, 5Delegación Jalisco IMSS, Guadalajara, Jalisco, Mexico
objeCtives: To determine HRQoL and patient satisfaction scores in colorectal can-
cer patients treated through radical surgery with a curative intent. Methods: Were 
selected colorectal cancer patients treated through radical surgery. One month after 
of the surgery we applied EORTC questionnaires QLQ-C30, CR29, and IN-PATSAT32. 
The scores for each questionnaire were calculated according formulas and instruc-
tion in the EORTC Scoring Manual. We calculated median and percentilar values 
25 and 75 for each score. Results: Were studies 83 colorectal cancer patients: 
34 women and 49 men, the results for EORTC questionnaires are: Global Health 
Status/QoL has a median score 83.33 (70.83-100); the functional scales: physical 93.33 
(83.33-100); emotional 83.33 (75-91.67); role 100 (83.33-100), social 100 (83.33-100). 
Symptoms scales: fatigue 11.11 (0.00-33.33); insomnia, 0.00 (0.00-0.00), pain 0.00 
(0.00-16.67), constipation 0.00 (0.00-33.33), financial difficulties 0.00 (0.00-33.33). For 
scales in CR29 questionnaire, the scores were: body image 100 (83.3-100), anxiety 
66.67 (66.67-100); sexual interest in women 0.00 (0.00-33.33), sexual interest male 
33.33 (0.00-33.33), urinary frequency 16.67 (0.00-33.33), blood stool 0.00 (0.00-16.67), 
stool frequency 0.00 (0.00-16.66), urinary incontinence 0.00 (0.00-0.00). About scores 
for IN-PATSAT32, for doctors: Interpersonal skills 100 (91.66-100); technical skills 
100 (95.83-100); capacity to bring information 100 (91.66-100); availability 100 (100-
100); for nurse: interpersonal skills 100 (91.66-100) technical skills 100 (83.33-100); 
capacity to bring information 91.67 (70.83-100); availability 87.50 (75.00-100); other 
personnel kindness 91.67 (83.33-100), access 87.50 (62.5-100), waiting time 87.50 
(62.5-100), exchange of information 100 (75-100), comfort/cleanness 75.00 (75.00-100) 
and general satisfaction 75.00 (75.00-100). ConClusions: The functional scales for 
QLQ-C30 showed a good quality of life, however symptom scales related to sexual 
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objeCtives: To explore individual’s preferences concerning genetic screening for 
colorectal cancer (CRC) within a population-based CRC screening program and to 
calculate the initial uptake of genetic screening for different scenarios based on 
the three major categories of genetic CRC; familial adenomatous polyposis (FAP), 
hereditary non-polyposis colorectal cancer or Lynch syndrome and other famil-
ial non-polyposis colorectal cancer (FCC). Methods: By means of ongoing data 
collection, a Discrete Choice Experiment (DCE) questionnaire was sent to a rep-
resentative sample of the Dutch population aged 55-65years. The DCE included 
nine D-efficient designed choice tasks. Panel-mixed-logit models were used to 
estimate the relative importance of the four included genetic screening attrib-
utes; risk of being genetically predisposed, risk of developing CRC, frequency of 
follow-up colonoscopies, survival rate. The potential uptake was calculated for the 
three screening scenarios. Results: When the chance of being genetically predis-
posed increased, respondents were more likely to participate in genetic screening. 
Respondents preferred biannual and annual colonoscopies over having a follow-up 
colonoscopy every 5 years. Increasing predicted CRC survival rates were associ-
ated with increased willingness to participate in screening. The risk of developing 
CRC as a result of being genetically predisposed did not impact the willingness of 
respondents to participate in screening. The frequency of follow-up colonoscopies 
was relatively most important for respondents when deciding about participation 
in genetic screening. The calculated potential uptake rates were high with respec-
tively 91.3% for the FCC, 91.9% for the Lynch and 91.0% for the FAP screening sce-
nario. ConClusions: Individuals are willing to participate in genetic screening for 
CRC. This decision is mostly driven by the frequency of follow-up colonoscopies, CRC 
survival rate and the chance of being genetically predisposed. This interest of the 
general public in genetic screening should be taken into account when discussing 
about the possibility of introducing genetic screening in population-based cancer 
screening programs.
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objeCtives: MBC is an incurable disease for which NVBOral is a standard treat-
ment available in 45 countries. The burden of disease, treatment patterns and 
motivation to choose across treatments and their consequences are seldom 
described in the real world. Methods: A prospective observational study was 
conducted to assess the global burden of disease and treatment with NVBOral or 
ivVino in Czech Republic, France, Germany, Italy, Poland and Spain. Patients and 
disease characteristics at inclusion, events, tolerability, hospitalisations observed 
during one cycle of treatment, and reasons to choose either route of administra-
tion are described. Eligible patients received NVBOral either alone or combined 
with capecitabine, or ivVino either alone or combined with capecitabine or tras-
tuzumab. Results: 184 patients were registered in 6 European countries: 128 
with NVBOral and 56 with ivVino. Patients’ characteristics differed significantly 
only in term of age (64 years for NVBOral and 58 years for ivVino, p= .001) and 
time between diagnosis and inclusion (104 and 71 months respectively, p= .002). 
NVBOral was mainly given to patients with HER2-negative (90%), estrogen-pos-
itive (80%) and progesterone-positive (62%) disease (ivVino: 66%, 66% and 51% 
respectively). Patients in the two cohorts had similar performance status and 
were similarly distributed across chemotherapy lines. NVBOral was mainly chosen 
for patients’ convenience (93%) and upon patients’ request (21%) (ivVino: 30% 
and 12% respectively). The two treatments were similarly safe, with grade 3/4 
neutropenia in 2% with NVBOral and 6% with ivVino, nausea and vomiting in 2% 
and none respectively. NVBOral was given without interruption, delay, or dose 
adjustment in 85% of patients (ivVino: 78%). Hospitalisation was required during 
the cycle observed for 14% and 26% of patients respectively. ConClusions: In 
this European prospective observational study, NVBOral appeared a safe, patient-
convenient and easy to manage treatment for MBC patients. NVBOral is used 
particularly after hormonal therapy.
PCN187
HealtH Related Quality of life aNd PatieNt satisfaCtioN iN PRostate 
CaNCeR PatieNts tReated tHRougH RadiCal PRostateCtoMy
Solano-Moreno H.1, Ramirez-Muñoz O.R.1, Balderas-Peña L.M.A.2, Flores-Larios E.A.3, 
Ramírez-Conchas R.E.2, Sat-Muñoz D.4, Salcedo-Rocha A.L.5, García de Alba-García J.E.5
1UMAE HE Centro Medico Nacional de Occidente Instituto Mexicano del Seguro Social, 
Guadalajara, Mexico, 2UMAE Hospital de Especialidades Centro Médico Nacional de Occidente 
IMSS, Guadalajara, Jalisco, Mexico, 3Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, 
4UMAE Hospital de Gineco-Obstetricia Centro Médico Nacional de Occidente IMSS, Guadalajara, 
Jalisco, Mexico, 5Delegación Jalisco IMSS, Guadalajara, Jalisco, Mexico
objeCtives: To determine HRQoL and patient satisfaction scores in prostate cancer 
patients treated through radical prostatectomy with a curative intent. Methods: 
Were selected prostate cancer patients treated through radical prostatectomy. One 
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receive information about it (p < 0,001). 95.74% of women to arouse the attention on 
breast cancer prevention advertisements. ConClusions: Results show that higher 
graduates are less appear on screening contrary to lower. Rate of self-examination is 
higher if family history of breast cancer known. Based on results, it is important to 
reach women who have not yet participated in preventive performances. The reduced 
activity of people living in cities should be improved, used of advantages of city. 
Important to organize a training program, especially for the correct application of the 
method and breast self-examination with usage of questionnaire.
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objeCtives: The main objective of our study was to assess the knowledge of 
HPV among the female university students in Hungary and also learn their atti-
tudes about the vaccine. Methods: The quantitative cross-sectional question-
naire survey was carried out among female students attending the University of 
Pécs Faculty of Health Sciences. 180 questionnaires were distributed, of which 165 
proved to be evaluable. χ 2-test and t-tests were performed as a statistical method 
besides 95% probability (p< 0.05). The data analysis was performed with SPSS 20.0 
programs. Results: 92% of the women knew the meaning of acronym HPV. 57 % 
of respondent women knew the cause of infection. 79.5% of the women knew about 
the virus causing lip and oral cavity cancer. 37.8% of the participants in the sam-
ple said that “only women”, and 62.2% of them said that “both men and women” 
were affected by the infection. It was known by more women who elderly (χ 2= 5,034, 
p= 0,024) and living in marriage or in partnership (χ 2= 7,415, p= 0,006). To sum up the 
analysis on the issues of HPV, those respondents were considered to be informed 
who responded well for 5 questions of 6 ones. This rate was 21.4% that is 32 partici-
pants of 149 women. 97,3% of respondent women had heard about the vaccination 
against HPV. 15 women of the respondents had HPV vaccination, among them there 
were significantly more single, divorced and widow persons. ConClusions: Overall 
the awareness of human papillomavirus of the students responding is low (21,4%). The 
against HPV vaccination does not happen because of the deficiencies in knowledge 
therefore this program is the most important task.
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objeCtives: To assess patient preference for the currently available bone-targeted 
agents (BTAs) used to prevent skeletal-related events (SREs; commonly defined as 
pathologic fracture, radiation to bone, surgery to bone and spinal cord compres-
sion) in Turkey. Methods: Adult patients with a self-reported physician diagnosis 
of bone metastases secondary to a solid tumor were recruited in several hospi-
tals to complete a pencil and paper discrete-choice experiment survey consisting 
of a series of 10 choices between pairs of hypothetical medication profiles. Each 
profile was defined using five attributes with several levels (based on prescribing 
information): time until first SRE (10,18 and 28 months); time until worsening of 
pain (3, 6 and 10 months); annual risk of osteonecrosis of the jaw (ONJ; 0, 1 and 5%); 
annual risk of renal impairment (0, 4 and 10%); and mode of administration (daily 
oral tablet, or subcutaneous injection, 15-minutes or 120-minute intravenous infu-
sion every 4 weeks). Twelve versions of the 10-questions were sequentially admin-
istrated across participants. A main-effects random parameters logit model was 
estimated. Results: A total of 91 patients were included in the analysis and pro-
vided demographic information. Among the attributes included in the survey, annual 
risk of renal impairment, time until worsening of pain and delaying SREs were the 
three most important attributes, with better levels of outcomes preferred to worse 
levels. Daily oral administration was the preferred mode of administration and there 
was no statistically significant difference between injection and infusion of differ-
ent durations. Annual risk of ONJ was judged by patients to be the least important 
attribute. ConClusions: When considering treatment choices, patients in Turkey 
focused mainly on the risk of renal impairment, the delay of pain worsening and 
delaying SREs.
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objeCtives: The aim of this study was to assess whether social media and disease-
specific patient forums can be valuable sources of information on what matters to 
patients and caregivers about their disease and its management. Methods: We 
investigated the accessibility of such information in breast cancer and schizophrenia. 
General social media websites and forums dedicated to sufferers of the two diseases 
were examined. Results: Breast cancer was more frequently mentioned in general 
social media websites than schizophrenia, with more charities, large organisations 
and fundraising events dedicated to breast cancer. Searches for breast cancer and 
schizophrenia on general social media sites result in hundreds of results, but these are 
mainly posted by advertisers or pharmaceutical companies, or contain non-patient 
opinions or news articles. Patients tend not to discuss their condition openly on 
general social media sites, whereas disease-specific forums contain daily entries on 
the patient experience. While searches within forums lead to fewer results, these are 
function showed a diminished QoL, satisfaction with doctors and nurses is good, 
but not for other hospital and doctors office conditions.
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objeCtives: To understand how the communication of risk in a discrete choice 
experiment (DCE) affects respondents’ choices. Methods: An online pilot DCE was 
designed to understand the preferences of female members of the public (recruited 
via an internet panel provider) for a breast screening programme described by three 
attributes (probability of detecting a cancer, risk of unnecessary treatment, and out-
of-pocket cost) each with four levels. Two versions were used that presented the 
risk attributes (probability of detecting a cancer and risk of unnecessary treatment 
per 100 women screened) as: (A) a percentage or (B) a percentage and risk image 
(icon array). The DCE was blocked into four surveys, each containing 10 choice sets. 
The design, generated using Ngene, included an internal validity test through the 
inclusion of a dominant choice set. The DCE data were analysed using conditional 
logit models. Results: 62 women completed the DCE (31 for each version A and 
B); all were currently eligible for screening under the current NHS programme. All 
coefficients, but no interactions, were significant and had the expected signs. Of 
the respondents who received the percentages only version, almost 20% failed the 
validity test (compared to only 3% of those who received the risk image). Probability 
of detecting a cancer was the most important attribute. Willingness-to-pay (WTP) 
for an additional cancer detected was £175 for respondents presented with the risk 
image, compared to only £152 in the percentages only group. Similarly, WTP to avoid 
an unnecessary treatment was £59 for respondents presented with the risk image 
compared to only £19 in the percentages only group. ConClusions: This pilot 
study highlights the impact attribute framing can have on respondents’ choices in 
a DCE. The use of risk images also resulted in fewer “irrational” responses implying 
respondents had a greater understanding of the task.
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objeCtives: The guideline on economic evaluations from the Swedish price and 
reimbursement authority (TLV) states that experience-based valuation of QALY 
weights are preferred before a hypothetical valuation. The UK hypothetical EQ-5D 
valuation set [Dolan 1997] has been used so far, but since 2013 an experience-
based “tariff” exists for the general population in Sweden [Burström 2013]. This 
study explores the implications on ICERs by applying the two different value 
sets. Methods: FACT-P mapped EQ-5D responses from patients with mCRPC in 
the AFFIRM trial [Skaltsa 2013; Scher 2012] were converted into utility weights using 
both the hypothetical and experience-based value sets. A Markov cohort cost-utility 
model (with stable, progressed and dead health states) analyzing enzalutamide 
(Xtandi®) vs. best supportive care (BSC) was used for studying the implications 
of applying the different utility weights. Results: As the experience-based value 
set had a more compressed event space, and was therefore less sensitive to QoL 
changes, the “on treatment” utility for Xtandi was 0.03 vs. 0.06 (hypothetical). The 
stable and progressed health states attained utility weights of: 0.688 and 0.603, 
respectively (hypothetical); 0.826 and 0.784, respectively (experienced). The sur-
vival gain with Xtandi vs. BSC in combination with the lower hypothetical health 
state utility weights resulted in a QALY gain of 0.66 vs. 0.75 with the experienced 
weights. With an incremental cost of € 51,100 (€ 1= 9SEK) the resulting ICER was 
€ 77,600 and € 68,200 using the hypothetical and experience-based value sets, respec-
tively. ConClusions: The Swedish experience-based EQ-5D value set generates a 
greater absolute utility but with a more compressed event space compared to the 
UK hypothetical value set. In terms of ICERs, this tends to favour technologies that 
extend survival compared to QoL improving technologies, although Xtandi provides 
both. These implications exert great challenge on Swedish decision makers on how 
the Swedish value set should be implemented.
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objeCtives: Aims to gain knowledge about the rate of breast screening among 
Hungarian women. In addition are they familiar with the concept of self-examina-
tion, with procedure and if so, whether it is used and how often. Also would like to 
develop an educational program based on results, which would target risk groups 
and self-examination and process would receive priority in prevention activities of 
breast cancer. Methods: A descriptive, cross-sectional, prospective and quantitative 
study made with women living in and around Sárvár, Hungary. Inclusion criteria was 
considered the group of women over 45 years. A non-random, convenience sampling 
was applied with 100 women, between January and June, 2013. Data collected with a 
questionnaire of 31 questions. Descriptive statistics with frequency range, Chi2-test 
was performed with Microsoft Excel 2007. Results: There is a significant difference 
between the appearance of screening and the distance from medical centre (p < 0.05). 
A higher proportion of women with higher education recognized therapeutic options 
for breast cancer than those with lower education (p < 0.05). For women where breast 
cancer was diagnosed in family history, 80% of them regularly attend screening. The 
women participate in less complex programs for the prevention, because they did not 
